Retatrutide

$100.00
Retatrutide is a novel GGG tri-agonist that simultaneously targets GLP-1, GIP, and glucagon receptors. By activating the glucagon receptor in addition to GLP-1 and GIP pathways, it promotes fat and glycogen breakdown, thereby boosting basal metabolic rate and supporting sustained fat loss. Its effects on appetite suppression and delayed gastric emptying further enhance weight management. Compared to earlier GLP-1 agonists, Retatrutide offers a more comprehensive metabolic approach. Ongoing research continues to explore its full therapeutic potential.

SELANK

$30.00
Selank is a synthetic analogue of the naturally occurring peptide tuftsin, known for its potent anti-anxiety properties. It works by modulating the balance of neurotransmitters in the brain, helping to reduce feelings of stress and anxiety. In addition to its anxiolytic effects, Selank has been shown to enhance memory and learning capabilities, making it beneficial for cognitive function. Furthermore, Selank has demonstrated positive effects on pain perception, helping to alleviate discomfort in various contexts. Due to these multifaceted benefits, Selank is being explored as a potential therapeutic agent for improving mental health, cognitive performance, and pain management.  

Semaglutide

$50.00
Semaglutide is a long-acting analogue of GLP-1, a naturally occurring peptide that helps regulate blood sugar by stimulating insulin secretion and suppressing glucagon in a glucose-dependent manner. In addition to its role in managing type 2 diabetes, semaglutide has shown benefits in reducing appetite, delaying gastric emptying, and promoting weight loss. Emerging studies also suggest potential protective effects on the heart, liver, and lungs, as well as possible neuroprotective properties relevant to Alzheimer’s disease. Its broad metabolic and systemic actions make it a key candidate in ongoing obesity and chronic disease research.

SEMAX

$30.00
Semax is a synthetic derivative of adrenocorticotrophic hormone (ACTH). Research indicates that it may increase brain-derived neurotrophic factor (BDNF), helping to improve immune function, protect neurons, and enhance cardiovascular health. Additionally, Semax shows promise in pain management and promoting blood clotting, making it a versatile therapeutic peptide.

Snap-8

$20.00
SNAP-8 is a peptide mimic of the N-terminal end of SNAP-25, which competes for a position in the SNARE complex, modulating its formation. By slightly destabilizing the SNARE complex, SNAP-8 prevents efficient neurotransmitter release, thereby reducing muscle contraction. This attenuation of muscle activity helps prevent the formation of lines and wrinkles, making SNAP-8 a promising anti-aging peptide.

SS-31

$38.00
SS-31 is a peptide that enhances mitochondrial function and ATP production, boosting cellular energy. Research has demonstrated its ability to reduce inflammatory cytokines associated with oxidative stress, which contribute to diseases such as Alzheimer's, Parkinson's, heart disease, diabetes, and kidney disease. SS-31 shows promise as a therapeutic agent for a range of inflammatory and age-related conditions.

Survodutide

$120.00
Survodutide is a dual agonist of GLP-1 and glucagon receptors, developed by Boehringer Ingelheim in collaboration with Zealand Pharma. It is being studied for the treatment of obesity and non-alcoholic steatohepatitis (NASH). By combining GLP-1–mediated appetite suppression with glucagon-induced energy expenditure and fat metabolism, survodutide has shown promising effects on weight reduction and liver fat reduction. In clinical trials, survodutide significantly reduced body weight and improved markers of liver health, making it a potential candidate for treating both obesity and metabolic liver disease. Ongoing phase 2 studies aim to confirm its long-term efficacy and safety.

TB500 (TB-500)

$70.00
TB-500 (Thymosin Beta-4) is a synthetic 43-amino acid peptide studied for its role in tissue repair and regeneration. In animal models, it promotes blood vessel formation, accelerates wound healing, reduces inflammation, and protects against oxidative damage in the heart and nervous system. TB-500 is actively researched for applications in recovery from injury and age-related tissue degeneration.

Tirzepatide

$55.00
Tirzepatide is a synthetic dual agonist that targets both the GIP and GLP-1 receptors. This unique mechanism allows it to lower blood glucose levels, improve insulin sensitivity, and significantly enhance satiety, leading to reduced food intake. Initially developed for the treatment of type 2 diabetes, Tirzepatide has also shown promising results in promoting weight loss and offering cardiovascular protection. Its dual action makes it a novel and powerful candidate in the management of metabolic disorders.